<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          Global EditionASIA 中文雙語Fran?ais
          Business
          Home / Business / Companies

          Online pharmacies may list abroad

          By Zheng Yiran | China Daily | Updated: 2018-10-22 10:26
          Share
          Share - WeChat
          A visitor reads a brochure at the Ping An Good Doctor's booth during the World Artificial Intelligence Conference in Shanghai on Sept 21. [Photo provided to China Daily]

          111 Inc's Nasdaq IPO, Ping An Health Cloud's float in Hong Kong likely to spark a trend

          111 Inc, China's largest online pharmacy and healthcare service provider that started trading its American Depositary Shares on the Nasdaq stock market in September, is expected to inspire other firms to list overseas or in Hong Kong, market insiders said.

          Many popular online pharmacies in China are subsidiaries of established listed pharmaceutical companies. For instance, 360Kad belongs to Taiantang Pharmaceutical Co Ltd, Ehaoyao is from the Jointown Pharmaceutical Group, and Kede is under Conba Group.

          Market insiders said online pharmacies began as startups, so are preparing to list in the near future to raise funds for their planned expansion and diversification, and to create an exit route for existing investors.

          On Sept 12, 111 Inc raised $100 million from 8.25 million ADS at $14 apiece, at the lower end of the $14-$16 range. However, the amount raised was lower than $148.8 million it targeted from the planned issuance of 9.3 million ADS.

          "Floating on Nasdaq is both a milestone and a starting point for 111 Inc, and our mission is much bigger than public listing on the stock market," said Yu Gang, co-founder and executive chairman of 111 Inc.

          Yu told media that the high standards and transparency of Nasdaq would push the company toward greatness.

          Many online pharmacies have already raised multiple rounds of financing; investors need to withdraw, and listing is inevitable, said Zhang Yibing, general manager of AKang Pharmacy, in an interview to Healthpoint, a network of healthcare and related services.

          After online drugstore Jianke raised $50 million in its A round, its CEO Xie Fangmin said: "The company is well-prepared to list in the United States. We estimate to start trading on the Nasdaq stock market in the coming two to three years, and the company will possibly list on other main boards (as well)."

          Zou Yuming, former executive director of JP Morgan, was appointed senior vice-president of Jianke, sparking speculation that the company may be preparing to list.

          Chen Qiaoshan, a medical analyst at Beijing-based market consultancy Analysys, said: "Online pharmacies have a clear profit model. Currently, the government has favorable policies for them, in that the nation allows prescription drugs to be sold online.

          "Being listed on the market is beneficial to these online companies' development, no matter they want to extend offline pharmacy or cooperate with physical hospitals."

          Wang Yanxiong, founder of 360Kad, told Healthpoint that companies are also inspired by Ping An Health Cloud Co Ltd, an online pharmacy that listed in Hong Kong in May. Its estimated market value reached tens of billion yuan.

          Online pharmacies and Ping An Health Cloud are seen as being under the same healthcare umbrella.

          After listing in Hong Kong, sales revenues of Ping An Health Cloud reached 1.12 billion yuan ($162 million) in the first half of this year, according to its financial report. The health business was its fastest-growing section, yielding 628 million yuan in sales, over half of the total.

          According to the prospectus of 111 Inc, the company's sales revenue last year was 960 million yuan, and that of the first half of this year reached 731 million yuan.

          However, the company is still reeling from losses. In 2017, the company's net loss narrowed by 31 percent to 249 million yuan, and that of the first six months of this year was 129 million yuan.

          In 2017, the business-to-customer or B2C section of 111 Inc was valued at 862 million yuan, while the business-to-business or B2B side was valued at 86.89 million yuan. Although running for only over a year, its B2B business is growing rapidly, with the sales revenue reaching 317 million yuan in the first half of this year.

          The proportion of its B2B business increased from 9 percent in 2017 to 43.3 percent in the first half of this year. By the end of 2017, its B2B business had covered 48,000 pharmacies, and the repurchase rate of its B2B pharmacies was up to 66.5 percent.

          Top
          BACK TO THE TOP
          English
          Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          CLOSE
           
          主站蜘蛛池模板: 国产精品中文字幕免费| 日本三级理论久久人妻电影| 国内精品久久久久影院薰衣草| 国产AV影片麻豆精品传媒| 18禁亚洲一区二区三区| 蜜臀av黑人亚洲精品| 欧美中日韩免费观看网站| 性饥渴少妇av无码毛片| 无码人妻精品一区二| 国产精品老年自拍视频| 免费无码高H视频在线观看| 日本久久一区二区免高清| 69精品无人区国产一区| 激情在线一区二区三区视频| 九九在线精品国产| 亚洲国模精品一区二区| 久久久久成人片免费观看蜜芽| 亚洲成人av免费一区| 免费无码又爽又刺激高潮的app| 性视频一区| 妲己丰满人熟妇大尺度人体艺| 搡老女人老妇女老熟女o在线阅读| 欧美丰满熟妇性XXXX| 亚洲人成网站观看在线观看 | 免费看成人毛片无码视频| 亚洲乱亚洲乱妇| 亚洲日产无码av| 国产乱码日韩精品一区二区| 亚洲精品国产中文字幕| 亚洲成人av日韩在线| 91久久性奴调教国产免费| 日本亚洲色大成网站www久久| 亚洲人成亚洲人成在线观看| 无遮挡边吃摸边吃奶边做| 天堂va蜜桃一区二区三区| 狠狠综合av一区二区| 99久久机热/这里只有精品| 国产一区二区三区亚洲精品| 亚洲国产一区二区三区四| 国产午夜福利精品视频| 久久综合亚洲色一区二区三区|